Your Company Doesn’t Want You to Take Ozempic for Weight Loss. Here’s Why.

May 22, 2023

(Wall Street Journal) – Many Americans seeking out drugs like Ozempic to shed pounds are hitting a barrier: Their employers’ health plans won’t pay for them. The issue is an emerging fault line in U.S. workplaces, driven by the social-media and celebrity buzz around Ozempic and its sister drug, Wegovy. Prescriptions for the treatments have soared so much that the drugs’ maker has often struggled to keep pace with demand. Yet companies, already facing rising healthcare costs, are wary of footing the bill for medicines that list for $900 or more a month. (Read More)